CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.07B, above the global median of $1.18B
- FinancialsHigh earnings quality
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.12%Above 5Y avg (1.27%)
Annual Rate
CNY 0.70Paid annual
Payout Ratio
51.7%Sustainable
Payback Period
29.0 yr
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
20.68BCNY3.07B · vs all stocks (USD)
Trailing P/E
19.03xRevenue (TTM)
4.43BCNY658.37M · vs all stocks (USD)
Profit Margin
24.15%Beta
-0.1940xvs all stocks
52-Week Change
-48.67%vs all stocks
Market Capitalization
20.68BCNY3.07B · vs all stocks (USD)
Enterprise Value
13.59BCNY2.02B · vs all stocks (USD)
Trailing P/E
19.03xForward P/E
14.24xPrice to Sales (TTM)
4.59xPrice to Book (MRQ)
2.12xEnterprise to Revenue
3.07xEnterprise to EBITDA
9.78xGross Margin
88.66%Profit Margin
24.15%Operating Margin
32.97%Return on Assets (TTM)
7.24%Return on Equity (TTM)
11.30%Revenue (TTM)
4.43BCNY658.37M · vs all stocks (USD)
Revenue per Share (TTM)
4.80CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-12.70%Gross Profit (TTM)
3.97BCNY589.93M · vs all stocks (USD)
EBITDA (TTM)
1.30BCNY193.54M · vs all stocks (USD)
Net Income (TTM)
1.07BCNY158.98M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-23.10%Operating Cash Flow (TTM)
1.41BCNY210.14M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
579.96MCNY86.14M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.7000CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
3.12%vs all stocks
5-Year Average Dividend Yield
1.27%vs all stocks
Payout Ratio
51.72%Minority Interest (Equity)
-24.27MCNYFY2025 · Dec 31, 2025Revenue
4.59BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
465.41MCNYFY2025 · Dec 31, 2025Gross Profit
4.12BCNYFY2025 · Dec 31, 2025Operating Income
1.30BCNY192.45M · vs all stocks (USD)
Pre-tax Income
1.36BCNYFY2025 · Dec 31, 2025Income Tax Expense
210.61MCNYFY2025 · Dec 31, 2025Net Income
1.15BCNYFY2025 · Dec 31, 2025EBIT
1.30BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.54BCNYFY2025 · Dec 31, 2025Research & Development
533.09MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.19BCNYFY2025 · Dec 31, 2025Other Operating Expenses
59.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
53.35MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.26CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.26CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
922.99MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
922.99MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.15BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
17.46MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.25BCNYFY2025 · Dec 31, 2025Free Cash Flow
991.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
6.38BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.15BCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.19MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-3.01MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
104.99MCNYFY2025 · Dec 31, 2025Capital Expenditures
-262.27MCNYFY2025 · Dec 31, 2025Purchase of Investments
-5.96BCNYFY2025 · Dec 31, 2025Sale of Investments
5.99BCNYFY2025 · Dec 31, 2025Other Investing Activity
16.00KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-225.37MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-552.67MCNYFY2025 · Dec 31, 2025Other Financing Charges
33.15MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-519.52MCNYFY2025 · Dec 31, 2025Shares Outstanding
921.32MSharesUpdated Aug 20, 2026Float Shares
280.26MSharesUpdated Aug 20, 2026% Held by Insiders
69.58%vs all stocks
% Held by Institutions
9.16%vs all stocks
Total Cash (MRQ)
6.71BCNY997.16M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.29CNYUpdated Aug 20, 2026Total Debt (MRQ)
2.20MCNY327.12K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0002xCurrent Ratio (MRQ)
12.70xBook Value per Share (MRQ)
10.43CNYUpdated Aug 20, 2026Total Assets
9.92BCNY1.47B · vs all stocks (USD)
Total Current Assets
7.08BCNYFY2025 · Dec 31, 2025Total Liabilities
645.22MCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.84BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
43.50MCNYFY2025 · Dec 31, 2025Total Current Liabilities
601.72MCNYFY2025 · Dec 31, 2025Cash
6.44BCNYFY2025 · Dec 31, 2025Cash Equivalents
11.44KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
6.44BCNYFY2025 · Dec 31, 2025Accounts Receivable
189.10MCNYFY2025 · Dec 31, 2025Inventory
407.05MCNYFY2025 · Dec 31, 2025Accounts Payable
221.43MCNYFY2025 · Dec 31, 2025Short-term Debt
1.68MCNYFY2025 · Dec 31, 2025Other Current Liabilities
153.56MCNYFY2025 · Dec 31, 2025Long-term Debt
1.82MCNYFY2025 · Dec 31, 2025Common Stock (Book)
921.32MCNYFY2025 · Dec 31, 2025Retained Earnings
5.83BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.27BCNY1.38B · vs all stocks (USD)
52-Week Low
18.97CNYUpdated Aug 20, 202652-Week High
44.40CNYUpdated Aug 20, 202652-Week Change
-48.67%vs all stocks
Beta
-0.1940xvs all stocks
50-Day MA
21.60CNYUpdated Aug 20, 2026200-Day MA
26.64CNYUpdated Aug 20, 2026Avg 10-Day Volume
10.23MSharesUpdated Aug 20, 2026Avg 30-Day Volume
10.71MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
1.16CNYUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.75
High structural barrier to entryNotable
Barrier to Entry: 0.60
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.07B, above the global median of $1.18BNotable
Market cap (USD): 3,071,954,507.612Global Median: 1,179,398,897.704
Revenue is $658.37M, above the global median of $534.05MNotable
Revenue (USD): 658,369,683.681Global Median: 534,052,387.958
Levered free cash flow is $86.14M, above the global median of $19.19MNotable
Levered free cash flow (USD): 86,135,421.568Global Median: 19,189,974.917
Companies that share the same coordination system — how they create, deliver, or capture value.
Sellas Life Sciences Group Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai Haoyuan Chemexpress Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Maravai Lifesciences Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRule
Alumis Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
BioArctic AB
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beam Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hybio Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Walvax Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tarsus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Arcutis Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Havells India Ltd.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
ALK-Abello A/S
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
HDFC Asset Management Co. Ltd.
2 interpretationsMulti-Year Revenue, Profit, And Income GrowthMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities